PDCD1 and cancer: In addition, on the basis of reports of clinical findings obtained using PD-1 inhibitors, longstanding theories regarding cancer immune surveillance [92] and cancer immunoediting, including the mechanism of cancer immune escape [93, 94], have recently been confirmed by fundamental research on tumor immunology.